Bodyport
Bodyport, based in San Francisco, develops the Bodyport Cardiac Scale, a device for non-invasive cardiac monitoring, utilizing AI to enhance heart failure management.
Company Overview
Bodyport is a healthcare technology company based in San Francisco, CA, USA. The company focuses on consumer health and wellness, particularly in the area of cardiac health. Founded with a mission to innovate non-invasive health monitoring solutions, Bodyport combines advanced technology and medical science to help prevent and manage heart conditions.
Key Product: Bodyport Cardiac Scale
The Bodyport Cardiac Scale is the primary product developed by Bodyport. This set of weighing scales is designed to non-invasively assess fluid status and heart function. The device detects signals through the feet when a patient steps onto the scale, and it transmits data on cardiac hemodynamic parameters to clinicians via cellular networks. The data helps healthcare professionals monitor and manage patients' heart health remotely.
FDA 510(k) Clearance
The Bodyport Cardiac Scale has received FDA 510(k) clearance, which signifies that the product meets regulatory requirements for safety and effectiveness. This clearance allows the device to be used officially for the non-invasive monitoring and management of patients with fluid management-related health conditions.
AI-Based Algorithms for Early Detection
Bodyport integrates AI-based algorithms into its Cardiac Scale to identify a variety of hemodynamic biomarkers. These algorithms support the early identification and diagnosis of potential heart issues. By continuously monitoring these biomarkers, clinicians can better predict and prevent worsening heart conditions.
Study: SCALE-HF
Bodyport introduced the SCALE-HF study, a multi-phase research initiative to develop and validate a composite index aimed at predicting heart failure events. Using multiple noninvasive hemodynamic biomarkers collected when a patient uses the Bodyport Cardiac Scale, the study aims to refine the Heart Function Index (HFI) algorithm for better patient monitoring and risk prevention.
Notable Investors
Bodyport is supported by prominent investors, including Boehringer Ingelheim Venture Fund, Initialized Capital, Playground Global, Rock Health, and Y Combinator. These investors provide strategic support and financial backing to drive the company's innovation and growth in the healthcare technology industry.